106333

CellPrime^® R³ IGF-I human

• Synonym(e): CellPrime^® R³ IGF-I human
• Empirische Formel (Hill-System): C₄₀₀H₆₁₉N₁₁₁O₁₁₅S₉
• CAS-Nummer: 143045-27-6
• Molekulargewicht: 9111.45

Eigenschaften

• Anwendung(en): pharma/biopharma processes; pharmaceutical
• Qualitätsniveau: 500
• Lagertemp.: 2-8°C

Beschreibung

Allgemeine Beschreibung

CellPrime® rLR3 IGF is a is a non-animal origin (NAO) recombinant equivalent Insulin-like growth factor expressed in E.coli. CellPrime® rLR3 IGF has a 13 amino acid N-terminal extension and position 3 substitution of Glutamic acid to Arginine contributes to increased stability and robustness in media formulations.

Anwendung

CellPrime® rLR3 IGF is used to optimize cell culture formulations to increase cell proliferation, productivity, and viability. With an exact match for the Type I IGF receptor and a lower affinity for IGF binding proteins, CellPrime® rLR3 IGF has increased effectiveness in serum-free cell culture media. Concentrations required to enhance performance is unique to each cell line and may be optimized by using in combination with CellPrime® rInsulin.

Verpackung

106333.0005 / 5 MG /
106333.0050/ 50 MG /
106333.0250/ 250 MG /
106333.0500 / 500 MG /

Rechtliche Hinweise

CellPrime is a registered trademark of Merck KGaA, Darmstadt, Germany

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable